Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Smith

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
ACS Chemical Biology|November 28, 2018
Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer TherapyOlga V Zubkova, Yassir A Ahmed, Scott E Guimond, et al.
Cytotherapy|March 1, 2022
Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansionAkshaya Srinivasan, Padmapriya Sathiyanathan, Lu Yin, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Plos One|February 9, 2023
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H Powers, David A Lindholm, et al.
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ACS Chemical Biology|November 28, 2018
Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer TherapyOlga V Zubkova, Yassir A Ahmed, Scott E Guimond, et al.
Cytotherapy|March 1, 2022
Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansionAkshaya Srinivasan, Padmapriya Sathiyanathan, Lu Yin, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Plos One|February 9, 2023
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H Powers, David A Lindholm, et al.
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Pageof 2